Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia.

Authors :: Larsen CM
Villarraga HR
Begna KH
Litzow MR
Al-Kali A
Herrmann J
Source :: Leukemia & lymphoma [Leuk Lymphoma] 2018 Jan; Vol. 59 (1), pp. 229-232. Date of Electronic Publication: 2017 Jun 08.
Publication Year :: 2018

Subjects :: Acute Disease
Aged
Antineoplastic Combined Chemotherapy Protocols adverse effects
Cardiovascular Diseases chemically induced
Cardiovascular Diseases physiopathology
Disease-Free Survival
Female
Humans
Leukemia, Myeloid pathology
Male
Middle Aged
Pyrimidines administration & dosage
Pyrimidines adverse effects
Retrospective Studies
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Cardiovascular Diseases diagnosis
Leukemia, Myeloid drug therapy

Full Text Access

Tools